Reading Hospital (McGlinn Family Regional Cancer Center) — West Reading, Pennsylvania

Reading Hospital (McGlinn Family Regional Cancer Center) is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Reading Hospital (McGlinn Family Regional Cancer Center) has participated in 1 clinical trials.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Reading Hospital (McGlinn Family Regional Cancer Center)?

Reading Hospital (McGlinn Family Regional Cancer Center) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Reading Hospital (McGlinn Family Regional Cancer Center) conducted?

Reading Hospital (McGlinn Family Regional Cancer Center) has 1 clinical trials on record. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Reading Hospital (McGlinn Family Regional Cancer Center) accredited by Crixeo Health?

Reading Hospital (McGlinn Family Regional Cancer Center) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Reading Hospital (McGlinn Family Regional Cancer Center)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.